Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial. [electronic resource]
Producer: 20210616Description: 1731-1738 p. digitalISSN:- 2374-2445
- Administration, Intravenous
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Bevacizumab -- administration & dosage
- Carcinoma, Ovarian Epithelial -- drug therapy
- Drug Administration Schedule
- Drug Synergism
- Female
- Humans
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Nivolumab -- administration & dosage
- Survival Analysis
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.